Dr. Muzafar Ahmad Macha

Assistant Professor

Curriculum Vitae

View

Contact Info

muzafar.aiiims@gmail.com
8082326900

Research Links


Google Scholar
ORCID
Other
ResearchGate

Overview

77

Publications

31

Conferences

6

Books

8

Book Chapters

8

Projects

5

FDP/ Workshops

5

Scholars

4

Patents

Overview

77

Total Publications

AuthorType	Total
First Author	10
Corresponding Author	22
Co-Author	45

Indexing	Total
UGC-CARE List Group II (Both Scopus and Web of Science)	72

Publication Details

The future of cancer treatment: combining radiotherapy with immunotherapy

Acceptance Date	12-06-2024
Publication Date Online	09-09-2024
Publication Date	09-09-2024
DOI	doi: 10.3389/fmolb.2024.1409300.
Number of Authors	14
ISSN	2296-889X
EISSN	2296-889X
Journal	Frontiers in Molecular Biosciences
Listed In Thomson	True
Impact Factor	3.9
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	11
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/39044839/
Web Link Journal	https://www.frontiersin.org/journals/molecular-biosciences
Proof
Author Type	Co-Author
Author Serial	5
Affiliating Institute	Islamic University of Science and Technology

Integrating network analysis with differential expression to uncover therapeutic and prognostic biomarkers in esophageal squamous cell carcinoma

Acceptance Date	30-07-2024
Publication Date Online	21-08-2024
Publication Date	21-08-2024
DOI	doi: 10.3389/fmolb.2024.1425422
Number of Authors	15
ISSN	2296-889X
EISSN	2296-889X
Journal	Frontiers of molecular Biosciences
Listed In Thomson	True
Impact Factor	3.9
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	0
Issue Number	11
Web Link	https://pubmed.ncbi.nlm.nih.gov/39234567/
Web Link Journal	https://www.frontiersin.org/journals/molecular-biosciences
Proof
Author Type	Corresponding Author
Author Serial	15
Affiliating Institute	Islamic University of Science and Technology

Addressing data imbalance challenges in oral cavity histopathological whole slide images with advanced deep learning techniques

Acceptance Date	07-07-2024
Publication Date Online	26-07-2024
Publication Date	26-07-2024
DOI	https://doi.org/10.1007/s13198-024-02440-6
Number of Authors	6
ISSN	0975-6809
EISSN	0976-4348
Journal	International Journal of System Assurance Engineering and Management
Listed In Thomson	False
Impact Factor	1.6
Source of Impact Factor	Official Website of the Journal
UGC Care List	UGC-CARE List Group II (Scopus Only)
Volume Number	0
Issue Number	0
Web Link	https://link.springer.com/article/10.1007/s13198-024-02440-6
Web Link Journal	https://link.springer.com/journal/13198
Proof
Author Type	Co-Author
Author Serial	3
Affiliating Institute	Islamic University of Science and Technology

A weakly supervised deep learning approach for guiding ovarian cancer treatment in prognosis: gigapixel histopathology analysis for personalized therapeutic response

Acceptance Date	13-06-2024
Publication Date Online	03-07-2024
Publication Date	03-07-2024
DOI	https://doi.org/10.1007/s13198-024-02390-z
Number of Authors	6
ISSN	0975-6809
EISSN	0976-4348
Journal	International Journal of System Assurance Engineering and Management
Listed In Thomson	False
Impact Factor	1.6
Source of Impact Factor	Official Website of the Journal
UGC Care List	UGC-CARE List Group II (Scopus Only)
Volume Number	0
Issue Number	0
Web Link	https://link.springer.com/article/10.1007/s13198-024-02390-z
Web Link Journal	https://link.springer.com/journal/13198
Proof
Author Type	Corresponding Author
Author Serial	6
Affiliating Institute	Islamic University of Science and Technology

Bergenin inhibits the growth of human cervical cancer cells by decreasing Galectin-3 and MMP-9 expression

Acceptance Date	13-06-2024
Publication Date Online	03-07-2024
Publication Date	03-07-2024
DOI	doi: 10.1038/s41598-024-64781-3.
Number of Authors	17
ISSN	2045-2322
EISSN	2045-2322
Journal	Scientific Reports
Listed In Thomson	True
Impact Factor	3.8
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number
Issue Number	14
Web Link	https://pubmed.ncbi.nlm.nih.gov/38961106/
Web Link Journal	https://www.nature.com/srep/about
Proof
Author Type	Co-Author
Author Serial	12
Affiliating Institute	Islamic University of Science and Technology

Secretory Trefoil Factor 1 (TFF1) promotes gemcitabine resistance through chemokine receptor CXCR4 in Pancreatic Ductal Adenocarcinoma

Acceptance Date	30-06-2024
Publication Date Online	02-07-2024
Publication Date	02-07-2024
DOI	doi: 10.1016/j.canlet.2024.217097
Number of Authors	12
ISSN	1872-7980
EISSN	0304-3835
Journal	CANCER LETTERS
Listed In Thomson	True
Impact Factor	9.1
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	598
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/38964729/
Web Link Journal	https://www.sciencedirect.com/journal/cancer-letters/publish/guide-for-authors#:~:text=Guide%20for%20authors%20%2D%20Cancer%20Letters,3835%20%7C%20ScienceDirect.com%20by%20Elsevier
Proof
Author Type	Co-Author
Author Serial	8
Affiliating Institute	Islamic University of Science and Technology

Assessing glioma grading with self‑attention: comparative analysis of the diagnostic potential of different MRI sequences

Acceptance Date	26-06-2024
Publication Date Online	26-06-2024
Publication Date	26-06-2024
DOI	doi.org/10.1007/s13198-024-02401-z
Number of Authors	5
ISSN	0975-6809
EISSN	0976-4348
Journal	Int J Syst Assur Eng. Manag
Listed In Thomson	False
Impact Factor	1.6
Source of Impact Factor	journal website
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	0
Issue Number	11
Web Link	https://link.springer.com/article/10.1007/s13198-024-02401-z/metrics
Web Link Journal	https://link.springer.com/journal/13198
Proof
Author Type	Corresponding Author
Author Serial	4
Affiliating Institute	Islamic University of Science and Technology

Therapeutic Implications of Signaling Pathways and Tumor Microenvironment Interactions in Esophageal Cancer

Acceptance Date	03-06-2024
Publication Date Online	05-06-2024
Publication Date	05-06-2024
DOI	doi: 10.1016/j.biopha.2024.116873.
Number of Authors	8
ISSN	0753-3322
EISSN	1950-6007
Journal	Biomed Pharmacothery
Listed In Thomson	True
Impact Factor	6.9
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	176
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/38843587/
Web Link Journal	https://www.sciencedirect.com/journal/biomedicine-and-pharmacotherapy
Proof
Author Type	Co-Author
Author Serial	5
Affiliating Institute	Islamic University of Science and Technology

Pyrethroids and reproductive function: some endocrine disrupting perspectives from molecular simulations

Acceptance Date	30-08-2024
Publication Date Online	01-09-2024
Publication Date	03-06-2024
DOI	doi: 10.1007/s10646-024-02801-8.
Number of Authors	3
ISSN	0963-9292.
EISSN	1573-3017
Journal	ECOTOXICOLOGY
Listed In Thomson	True
Impact Factor	2.4
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	0
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/39214921/
Web Link Journal	https://link.springer.com/article/10.1007/s10646-024-02801-8
Proof
Author Type	Co-Author
Author Serial	3
Affiliating Institute	Islamic University of sciences and technology

10.

Alzhinet: an explainable self-attention based classification model to detect Alzheimer from 3D volumetric MRI data

Acceptance Date	19-05-2024
Publication Date Online	02-06-2024
Publication Date	02-06-2024
DOI	https://doi.org/10.1007/s13198-024-02377-w
Number of Authors	5
ISSN	0975-6809
EISSN	0976-4348
Journal	International Journal of System Assurance Engineering and Management
Listed In Thomson	False
Impact Factor	1.6
Source of Impact Factor	Official Website of the Journal
UGC Care List	UGC-CARE List Group II (Scopus Only)
Volume Number	0
Issue Number	0
Web Link	https://link.springer.com/article/10.1007/s13198-024-02377-w
Web Link Journal	https://link.springer.com/journal/13198
Proof
Author Type	Corresponding Author
Author Serial	4
Affiliating Institute	Islamic University of Science and Technology

11.

Deep learning-based identification of esophageal cancer subtypes through analysis of high-resolution histopathology images

Acceptance Date	23-02-2024
Publication Date Online	19-03-2024
Publication Date	19-03-2024
DOI	https://doi.org/10.3389/fmolb.2024.1346242
Number of Authors	9
ISSN	NA
EISSN	2296-889X
Journal	Frontiers in Molecular Biosciences
Listed In Thomson	False
Impact Factor	3.9
Source of Impact Factor	Official Website of the Journal
UGC Care List	UGC-CARE List Group II (Web of Science Only)
Volume Number	11
Issue Number	0
Web Link	https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2024.1346242/full
Web Link Journal	https://www.frontiersin.org/journals/molecular-biosciences
Proof
Author Type	Corresponding Author
Author Serial	8
Affiliating Institute	Islamic University of Science and Technology

12.

Cancer Cell Plasticity: From Cellular, molecular, and Genetic Mechanisms to Tumor Heterogeneity and Drug Resistance

Acceptance Date	24-01-2024
Publication Date Online	08-02-2024
Publication Date	08-02-2024
DOI	doi: 10.1007/s10555-024-10172-z.
Number of Authors	17
ISSN	0167-7659
EISSN	1573-7233
Journal	Cancer Metastasis Rev
Listed In Thomson	True
Impact Factor	10.3
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	1
Issue Number	43
Web Link	https://pubmed.ncbi.nlm.nih.gov/38329598/
Web Link Journal	https://link.springer.com/journal/10555
Proof
Author Type	Co-Author
Author Serial	13
Affiliating Institute	Islamic University of Science and Technology

13.

Metronomic chemotherapy and drug repurposing: a paradigm shift in oncology

Acceptance Date	11-01-2024
Publication Date Online	11-01-2024
Publication Date	11-01-2024
DOI	doi: 10.1016/j.heliyon.2024.e24670
Number of Authors	8
ISSN	24058440
EISSN	24058440
Journal	HELIYON
Listed In Thomson	True
Impact Factor	3.4
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	3
Issue Number	10
Web Link	https://pubmed.ncbi.nlm.nih.gov/38314272/
Web Link Journal	https://www.cell.com/heliyon/home
Proof
Author Type	Co-Author
Author Serial	6
Affiliating Institute	Islamic University of Science and Technology

14.

Extracellular vesicles as tools and targets in therapy for diseases

Acceptance Date	20-12-2023
Publication Date Online	24-12-2023
Publication Date	24-12-2023
DOI	doi: 10.1038/s41392-024-01735-1
Number of Authors	14
ISSN	2059-3635
EISSN	2059-3635
Journal	Signal Transduction and Targeted Therapy
Listed In Thomson	True
Impact Factor	39.9
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	1
Issue Number	9
Web Link	https://pubmed.ncbi.nlm.nih.gov/38311623/
Web Link Journal	https://www.nature.com/sigtrans/
Proof
Author Type	Co-Author
Author Serial	12
Affiliating Institute	Islamic University of Science and Technology

15.

CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond

Acceptance Date	12-11-2023
Publication Date Online	16-11-2023
Publication Date	16-11-2023
DOI	https://doi.org/10.3390/vaccines11111721
Number of Authors	20
ISSN	2076-393X
EISSN	2076-393X
Journal	VACCINES
Listed In Thomson	True
Impact Factor	6
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	11
Issue Number	11
Web Link	https://www.mdpi.com/2076-393X/11/11/1721
Web Link Journal	https://www.mdpi.com/journal/vaccines
Proof
Author Type	Co-Author
Author Serial	8
Affiliating Institute	Islamic University of sciences and Technology

16.

Epigenetic Modifications: Key Players in Cancer Heterogeneity and Drug Resistance

Acceptance Date	31-10-2023
Publication Date Online	04-11-2023
Publication Date	04-11-2023
DOI	10.1016/j.tranon.2023.101821
Number of Authors	7
ISSN	1944-7124
EISSN	1936-5233
Journal	Transl Oncol
Listed In Thomson	True
Impact Factor	5
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	39
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/37931371/
Web Link Journal	https://www.sciencedirect.com/journal/translational-oncology
Proof
Author Type	Co-Author
Author Serial	5
Affiliating Institute	Islamic University of sciences and technology

17.

Ubiquitin Specific Peptidase 37 and PCNA interaction promotes Osteosarcoma pathogenesis by modulating replication fork progression

Acceptance Date	10-10-2023
Publication Date Online	12-10-2023
Publication Date	12-10-2023
DOI	10.1186/s12967-023-04126-2
Number of Authors	18
ISSN	1479-5876
EISSN	1479-5876
Journal	Journal of Translational Medicine 21(1):286
Listed In Thomson	True
Impact Factor	6.9
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	21
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/37118828/
Web Link Journal	https://translational-medicine.biomedcentral.com/
Proof
Author Type	Co-Author
Author Serial	15
Affiliating Institute	Islamic University of sciences and technology

18.

Bernabeua M, Gharibzahedib SMT, Dar BN, Macha MA, Ganaie AA, Castagnini JM, Warrington Y, Martínez AJM, Altintas Z, Collado MC, Barba FJ (2023). The potential modulation of gut microbiota and oxidative stress by dietary carotenoid pigments. Critical Reviews in Food Science and Nutrition. 10:1-19. PMID: 37691412.

Acceptance Date	01-09-2023
Publication Date Online	23-09-2023
Publication Date	23-09-2023
DOI	10.1080/10408398.2023.2254383
Number of Authors	10
ISSN	1549-7852
EISSN	1549-7852
Journal	Critical Reviews in Food Science and Nutrition. 10:1-19.
Listed In Thomson	True
Impact Factor	11.203
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	0
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/37691412/
Web Link Journal	https://www.tandfonline.com/doi/full/10.1080/10408398.2023.2254383
Proof
Author Type	Co-Author
Author Serial	4
Affiliating Institute	Islamic University of sciences and technology

19.

Associations between Telomere Attrition, Genetic Variants in Telomere Maintenance Genes, and Non-Small Cell Lung Cancer Risk in the Jammu and Kashmir Population of North Indi, North India. Accepted with minor comments in BMC Cancer. 18; 23 (1):874. PMID: 37718447.

Acceptance Date	07-09-2023
Publication Date Online	18-09-2023
Publication Date	18-09-2023
DOI	10.1186/s12885-023-11387-z
Number of Authors	16
ISSN	0
EISSN	0
Journal	BMC Cancer. 18; 23 (1):874
Listed In Thomson	True
Impact Factor	4.3
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	1
Issue Number	0
Web Link	https://bmccancer.biomedcentral.com/articles/10.1186/s12885-023-11387-z#citeas
Web Link Journal	https://bmccancer.biomedcentral.com/
Proof
Author Type	Co-Author
Author Serial	13
Affiliating Institute	Islamic University of sciences and technology

20.

Holy Basil leaf extract decreases tumorogenecity and metastasis of aggressive human pancreatic cancer cells in vitro and in

Acceptance Date	01-08-2023
Publication Date Online	26-08-2023
Publication Date	26-08-2023
DOI	10.1016/j.canlet.2013.03.017
Number of Authors	15
ISSN	1872-7980
EISSN	1872-7980
Journal	Cancer Lett . 2013 Aug 19;336(2):270-80
Listed In Thomson	True
Impact Factor	9.756
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	0
Issue Number	2
Web Link	https://www.sciencedirect.com/science/article/abs/pii/S0304383513002450?via%3Dihub
Web Link Journal	https://www.sciencedirect.com/journal/cancer-letters
Proof
Author Type	Co-Author
Author Serial	12
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

21.

Harnessing the Power of CAR-T Cell Therapy: Progress, Challenges, and Future Directions

Acceptance Date	21-06-2023
Publication Date Online	07-07-2023
Publication Date	07-07-2023
DOI	10.1186/s12967-023-04292-3
Number of Authors	17
ISSN	1479-5876
EISSN	1479-5876
Journal	Journal of Translational Medicine
Listed In Thomson	True
Impact Factor	9
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	21
Issue Number	1
Web Link	https://pubmed.ncbi.nlm.nih.gov/37420216/
Web Link Journal	https://translational-medicine.biomedcentral.com/
Proof
Author Type	Co-Author
Author Serial	13
Affiliating Institute	Islamic University of sciences and technology

22.

Baba SK, Baba SK, Mir R, Elfaki I, Ullah MF, Barnawi J, Altemani FHA, Alenezi M, Mustafa SK, Masoodi T, Bhat AA, Macha MA§ (2023). Long non-Coding RNAs Modulate Tumor Microenvironment to Promote Metastasis: Novel Avenue for Therapeutic Intervention. Front Cell Dev Biol. 13;11:1164301. §Corresponding author. PMID: 37384249

Acceptance Date	22-05-2023
Publication Date Online	23-06-2023
Publication Date	23-06-2023
DOI	10.3389/fcell.2023.1164301
Number of Authors	12
ISSN	2296-634X
EISSN	2296-634X
Journal	Front Cell Dev Biol. 13;11:1164301
Listed In Thomson	True
Impact Factor	5.5
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	11
Issue Number	0
Web Link	https://www.frontiersin.org/articles/10.3389/fcell.2023.1164301/full
Web Link Journal	https://www.frontiersin.org/journals/cell-and-developmental-biology
Proof
Author Type	Corresponding Author
Author Serial	12
Affiliating Institute	Islamic University of sciences and technology

23.

Expression of HIF-1α and Markers of angiogenesis and metabolic adaptation in molecular subtypes of Breast Cancer.

Acceptance Date	14-01-2023
Publication Date Online	24-01-2023
Publication Date	24-01-2023
DOI	10.1186/s41231-023-00135-x
Number of Authors	12
ISSN	2396-832X
EISSN	2396-832X
Journal	Translational Medicine and Communications. 8;1-13.
Listed In Thomson	True
Impact Factor	0
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	2
Issue Number	0
Web Link	https://transmedcomms.biomedcentral.com/articles/10.1186/s41231-023-00135-x
Web Link Journal	https://transmedcomms.biomedcentral.com/
Proof
Author Type	Co-Author
Author Serial	11
Affiliating Institute	Islamic University of sciences and technology

24.

Bhat AA, Nisar S, Mukherjee S, #Saha N, #Yarravarapu N, #Lone SN, Masoodi T, Chauhan R, Hashem S, Bagga Pt, Reddy R, Bedognetti D, Uddin S, El-Rifai W, §Singh M, §Macha MA, §Haris M (2022). Integration of CRISPR/Cas9 with Artificial Intelligence for improved cancer therapeutics. J Transl Med. 18;20(1):534. §Corresponding authors. PMID: 36401282.

Acceptance Date	01-11-2022
Publication Date Online	18-11-2022
Publication Date	18-11-2022
DOI	10.1186/s12967-022-03765-1
Number of Authors	17
ISSN	1479-5876
EISSN	1479-5876
Journal	J Transl Med. 18;20(1):534
Listed In Thomson	True
Impact Factor	8.484
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	0
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/36401282/
Web Link Journal	https://translational-medicine.biomedcentral.com/
Proof
Author Type	Corresponding Author
Author Serial	16
Affiliating Institute	Islamic University of sciences and technology

25.

35. Mehraj U, Mushtaq U, Mir MA, Saleem A, Macha MA, Lone MN, Hamid A, Zargar MA, Ahmad SM, and Wani NA (2022). Chemokines in Triple-Negative Breast Cancer Heterogeneity: New Challenges for Clinical Implications. Semin Cancer Biol. 86(Pt 2):769-783. PMID: 35278636.

Acceptance Date	01-10-2022
Publication Date Online	01-11-2022
Publication Date	01-11-2022
DOI	10.1016/j.semcancer.2022.03.008
Number of Authors	10
ISSN	1096-3650
EISSN	1096-3650
Journal	Semin Cancer Biol. 86(Pt 2):769-783
Listed In Thomson	True
Impact Factor	14.5
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	86
Issue Number	0
Web Link	https://www.sciencedirect.com/science/article/abs/pii/S1044579X22000645?via%3Dihub
Web Link Journal	https://www.sciencedirect.com/journal/seminars-in-cancer-biology
Proof
Author Type	Co-Author
Author Serial	5
Affiliating Institute	Islamic University of sciences and technology

26.

#Nisar S, Masood T, #Prabhu KS, #Kuttikrishnan S, Zarif L, Khatoon S, Ali S, Uddin S, Akil A. Al-S, Singh M§, Macha MA§, Bhat AA§ (2022). Natural Products as Chemo-Radiation Therapy Sensitizers in Cancer. Biomed Pharmacother. 154:113610. §Corresponding author. PMID: 36030591.

Acceptance Date	24-08-2022
Publication Date Online	26-08-2022
Publication Date	26-08-2022
DOI	10.1016/j.biopha.2022.113610
Number of Authors	12
ISSN	1950-6007
EISSN	1950-6007
Journal	Biomed Pharmacother. 154:113610
Listed In Thomson	True
Impact Factor	7.5
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	154
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/36030591/
Web Link Journal	https://www.sciencedirect.com/journal/biomedicine-and-pharmacotherapy
Proof
Author Type	Corresponding Author
Author Serial	11
Affiliating Institute	Islamic University of sciences and technology

27.

Bhat AA, Nisar S, Singh M, Ashraf B, Masoodi T, Karedath T, Maacha S, Prasad CP, Sharma A, Hashem S, Frenneaux MP, Grivel JC, Rifai WE, Bedognetti D, Dhawan P, §Haris M, and §Macha MA (2022). Cytokine and Chemokine Induced Inflammatory Colorectal Tumor Microenvironment: Emerging Avenue for Targeted Therapy. Cancer Communications (Lond), 42(8):689-715. §Corresponding author. PMID: 35791509.

Acceptance Date	01-07-2022
Publication Date Online	22-07-2022
Publication Date	22-07-2022
DOI	10.1002/cac2.12295
Number of Authors	17
ISSN	2523-3548
EISSN	2523-3548
Journal	Cancer Communications (Lond), 42(8):689-715.
Listed In Thomson	True
Impact Factor	15.283
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	8
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/35791509/
Web Link Journal	https://onlinelibrary.wiley.com/journal/25233548
Proof
Author Type	Corresponding Author
Author Serial	17
Affiliating Institute	Islamic University of sciences and technology

28.

Targeting cancer signaling pathways by natural products: Exploring promising anti-cancer agents

Acceptance Date	26-04-2022
Publication Date Online	30-04-2022
Publication Date	30-04-2022
DOI	10.1016/j.biopha.2022.113054
Number of Authors	18
ISSN	0753-3322
EISSN	1950-6007
Journal	Biomedicine & Pharmacothery. 150:113054
Listed In Thomson	True
Impact Factor	7.5
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	150
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/35658225/
Web Link Journal	https://www.sciencedirect.com/journal/biomedicine-and-pharmacotherapy
Proof
Author Type	Corresponding Author
Author Serial	17
Affiliating Institute	Islamic University of sciences and technology

29.

Chaudhary S, Lakshmanan I, Ganti AK, Macha MA, Batra SK (2022). Comment on "Dual blockade of EGFR and CDK4/6 delays head and neck squamous cell carcinoma progression by inducing metabolic rewiring". Cancer Lett. (527):193-194. PMID: 35115095.

Acceptance Date	02-02-2022
Publication Date Online	23-03-2022
Publication Date	23-03-2022
DOI	10.1016/j.canlet.2021.04.004
Number of Authors	17
ISSN	0304-3835
EISSN	1872-7980
Journal	Cancer Lett. (527):193-194
Listed In Thomson	True
Impact Factor	9.756
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	510
Issue Number	0
Web Link	file:///C:/Users/Dr.%20Macha/Downloads/Cancer%20Letters%20Reply%202022.pdf
Web Link Journal	https://www.sciencedirect.com/journal/cancer-letters
Proof
Author Type	Corresponding Author
Author Serial	16
Affiliating Institute	Islamic University of sciences and technology

30.

Liquid Biopsy: A Step Closer to Transform Diagnosis, Prognosis and Future of Cancer Treatments

Acceptance Date	21-02-2022
Publication Date Online	18-03-2022
Publication Date	18-03-2022
DOI	10.1186/s12943-022-01543-7
Number of Authors	12
ISSN	1476-4598
EISSN	1476-4598
Journal	Molecular Cancer. 21(1):79
Listed In Thomson	True
Impact Factor	37
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	21
Issue Number	1
Web Link	https://pubmed.ncbi.nlm.nih.gov/35303879/
Web Link Journal	https://molecular-cancer.biomedcentral.com/
Proof
Author Type	Corresponding Author
Author Serial	12
Affiliating Institute	Islamic University of sciences and technology

31.

Exploring dysregulated signaling pathways in cancer

Acceptance Date	31-12-2021
Publication Date Online	31-12-2021
Publication Date	31-12-2021
DOI	0.2174/1381612826666200115095937
Number of Authors	10
ISSN	1873-4286
EISSN	1873-4286
Journal	Current Pharmaceutical Design
Listed In Thomson	True
Impact Factor	3.3
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	26
Issue Number	4
Web Link	https://www.ingentaconnect.com/content/ben/cpd/2020/00000026/00000004/art00004
Web Link Journal	https://www.eurekaselect.com/article/103653
Proof
Author Type	Co-Author
Author Serial	3
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

32.

Therapeutic effects of Curcumol in several diseases; An overview.

Acceptance Date	01-12-2021
Publication Date Online	06-12-2021
Publication Date	06-12-2021
DOI	10.1080/01635581.2020.1749676
Number of Authors	9
ISSN	0163-5581
EISSN	0163-5581
Journal	Nutrition and Cancer
Listed In Thomson	True
Impact Factor	2.816
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	73
Issue Number	2
Web Link	https://pubmed.ncbi.nlm.nih.gov/32285707/
Web Link Journal	https://pubmed.ncbi.nlm.nih.gov/32285707/
Proof
Author Type	Co-Author
Author Serial	4
Affiliating Institute	Central University of Kashmir

33.

Ubiquitin specific peptidase 37 (USP37), An important cog in oncogenic machinery of a cancerous cell

Acceptance Date	21-10-2021
Publication Date Online	10-11-2021
Publication Date	10-11-2021
DOI	10.1186/s13046-021-02163-7
Number of Authors	10
ISSN	1756-9966
EISSN	1756-9966
Journal	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Listed In Thomson	True
Impact Factor	11.5
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	356
Issue Number	0
Web Link	https://jeccr.biomedcentral.com/articles/10.1186/s13046-021-02163-7#citeas
Web Link Journal	https://jeccr.biomedcentral.com/
Proof
Author Type	Co-Author
Author Serial	8
Affiliating Institute	Islamic University of sciences and technology

34.

Differential gene expression-based connectivity mapping identified novel drug candidate and improved Temozolomide efficacy for Glioblastoma

Acceptance Date	01-10-2021
Publication Date Online	25-10-2021
Publication Date	25-10-2021
DOI	10.1186/s13046-021-02135-x
Number of Authors	14
ISSN	1756-9966
EISSN	1756-9966
Journal	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Listed In Thomson	True
Impact Factor	11.5
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	40
Issue Number	1
Web Link	https://pubmed.ncbi.nlm.nih.gov/34696786/
Web Link Journal	https://jeccr.biomedcentral.com/
Proof
Author Type	Co-Author
Author Serial	3
Affiliating Institute	Islamic University of sciences and technology

35.

Tumor Microenvironment as Driver of Stemness and Therapeutic Resistance in Breast Cancers: New Challenges and The

Acceptance Date	06-09-2021
Publication Date Online	16-09-2021
Publication Date	16-09-2021
DOI	10.1007/s13402-021-00634-9
Number of Authors	13
ISSN	2211-3428
EISSN	2211-3436
Journal	CELLULAR ONCOLOGY
Listed In Thomson	True
Impact Factor	6.1
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	44
Issue Number	6
Web Link	https://pubmed.ncbi.nlm.nih.gov/34528143/
Web Link Journal	https://link.springer.com/journal/13402
Proof
Author Type	Co-Author
Author Serial	3
Affiliating Institute	Islamic University of sciences and technology

36.

The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities

Acceptance Date	01-09-2021
Publication Date Online	16-09-2021
Publication Date	16-09-2021
DOI	10.1007/s13402-021-00634-9
Number of Authors	13
ISSN	2211-3428
EISSN	2211-3436
Journal	Cellular oncology (Dordrecht)
Listed In Thomson	True
Impact Factor	6.1
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	6
Issue Number	0
Web Link	https://link.springer.com/article/10.1007/s13402-021-00634-9
Web Link Journal	https://link.springer.com/journal/13402
Proof
Author Type	Co-Author
Author Serial	3
Affiliating Institute	Islamic University of sciences and technology

37.

miRNAs as novel immunoregulators in cancer

Acceptance Date	13-04-2021
Publication Date Online	27-04-2021
Publication Date	27-04-2021
DOI	10.1016/j.semcdb.2021.04.013
Number of Authors	16
ISSN	1084-9521
EISSN	1096-3634
Journal	Seminars in Cell and Developmental Biology
Listed In Thomson	True
Impact Factor	7.3
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	124
Issue Number	0
Web Link	https://www.sciencedirect.com/science/article/abs/pii/S1084952121000860
Web Link Journal	https://www.sciencedirect.com/journal/seminars-in-cell-and-developmental-biology
Proof
Author Type	Corresponding Author
Author Serial	16
Affiliating Institute	Islamic University of sciences and technology

38.

Chemokine-Cytokine Networks in the Head and Neck Tumor Microenvironment

Acceptance Date	05-04-2021
Publication Date Online	27-04-2021
Publication Date	27-04-2021
DOI	10.3390/ijms22094584
Number of Authors	12
ISSN	1422-0067
EISSN	1422-0067
Journal	International Journal of Molecular Sciences
Listed In Thomson	True
Impact Factor	5.6
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	22
Issue Number	9
Web Link	https://pubmed.ncbi.nlm.nih.gov/33925575/
Web Link Journal	https://www.mdpi.com/journal/ijms
Proof
Author Type	Corresponding Author
Author Serial	12
Affiliating Institute	Islamic University of sciences and technology

39.

Insights Into the Role of CircRNAs: Biogenesis, Characterization, Functional, and Clinical Impact in Human Malignancies

Acceptance Date	04-01-2021
Publication Date Online	05-02-2021
Publication Date	05-02-2021
DOI	10.3389/fcell.2021.617281
Number of Authors	17
ISSN	2296-634X
EISSN	2296-634X
Journal	Frontiers in Cell and Developmental Biology
Listed In Thomson	True
Impact Factor	6.081
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	9
Issue Number	0
Web Link	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7894079/
Web Link Journal	https://www.frontiersin.org/journals/cell-and-developmental-biology
Proof
Author Type	Co-Author
Author Serial	15
Affiliating Institute	Islamic University of sciences and technology

40.

Insights into the role of circRNAs: biogenesis, characterization, functional and

Acceptance Date	01-02-2021
Publication Date Online	05-02-2021
Publication Date	05-02-2021
DOI	10.3389/fcell.2021.617281
Number of Authors	17
ISSN	2296-634X
EISSN	2296-634X
Journal	Front Cell Dev Biol
Listed In Thomson	True
Impact Factor	6.081
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	9
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/33614648/
Web Link Journal	https://www.frontiersin.org/journals/cell-and-developmental-biology
Proof
Author Type	Co-Author
Author Serial	15
Affiliating Institute	Islamic University of sciences and technology

41.

Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy

Acceptance Date	15-10-2020
Publication Date Online	21-01-2021
Publication Date	21-01-2021
DOI	10.1038/s41392-020-00419-w
Number of Authors	12
ISSN	2059-3635
EISSN	2059-3635
Journal	Signal Transduction and Targeted Therapy
Listed In Thomson	True
Impact Factor	37.2
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	6
Issue Number	0
Web Link	https://www.nature.com/articles/s41392-020-00419-w
Web Link Journal	https://www.nature.com/sigtrans/
Proof
Author Type	Corresponding Author
Author Serial	12
Affiliating Institute	Islamic University of sciences and technology

42.

Chemokine-Cytokine Network Drives Esophageal Cancer Metastasis; Promising Avenue for Targeted Therapy.

Acceptance Date	02-01-2021
Publication Date Online	21-01-2021
Publication Date	21-01-2021
DOI	10.1186/s12943-020-01294-3
Number of Authors	20
ISSN	1476-4598
EISSN	1476-4598
Journal	Molecular Cancer. 2021, 4;20(1):2
Listed In Thomson	True
Impact Factor	41.44
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	2
Issue Number
Web Link	https://pubmed.ncbi.nlm.nih.gov/33390169/
Web Link Journal	https://molecular-cancer.biomedcentral.com/
Proof
Author Type	Corresponding Author
Author Serial	19
Affiliating Institute	Islamic University of sciences and technology

43.

Bhat AA, Yousuf P, Wani NA, Nisar S, Chauhan SS, Siddiqui MA, Bedognetti D, El-Rifai W, Frenneaux MP, Batra SK, Harris M§, Macha MA§ (2021). Tumor Microenvironment Mediated Aggressive Head and Neck Squamous Cell Carcinoma: Novel Avenue for Therapeutic Tar

Acceptance Date	01-12-2020
Publication Date Online	01-01-2021
Publication Date	01-01-2021
DOI	10.1038/s41392-020-00419-w
Number of Authors	12
ISSN	2059-3635
EISSN	2059-3635
Journal	Signal Transduct Target Ther . 2021 Jan 12;6(1):12.
Listed In Thomson	True
Impact Factor	37.2
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	1
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/33436555/
Web Link Journal	https://www.nature.com/sigtrans/journal-information
Proof
Author Type	Corresponding Author
Author Serial	12
Affiliating Institute	Islamic University of sciences and technology

44.

Non-invasive biomarkers for monitoring the immunotherapeutic response to cancer

Acceptance Date	01-12-2020
Publication Date Online	09-12-2020
Publication Date	09-12-2020
DOI	10.1186/s12967-020-02656-7
Number of Authors	11
ISSN	1479-5876
EISSN	1479-5876
Journal	Journal of Translational Medicine
Listed In Thomson	True
Impact Factor	6.9
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	18
Issue Number	1
Web Link	https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02656-7
Web Link Journal	https://translational-medicine.biomedcentral.com/
Proof
Author Type	Co-Author
Author Serial	1
Affiliating Institute	Islamic University of sciences and technology

45.

Differential mutation spectrum and immune landscape in African Americans versus Whites: A possible determinant to health disparity in head and neck cancer

Acceptance Date	25-07-2020
Publication Date Online	29-07-2020
Publication Date	29-07-2020
DOI	10.1016/j.canlet.2020.07.029
Number of Authors	8
ISSN	1872-7980
EISSN	1872-7980
Journal	Cancer Letters
Listed In Thomson	True
Impact Factor	9.756
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	492
Issue Number	0
Web Link	https://www.sciencedirect.com/science/article/abs/pii/S0304383520303864
Web Link Journal	https://www.sciencedirect.com/journal/cancer-letters
Proof
Author Type	Corresponding Author
Author Serial	7
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

46.

Odyssey of Trefoil factors in Cancers: Diagnostic and Therapeutic Implications

Acceptance Date	01-04-2020
Publication Date Online	13-04-2020
Publication Date	13-04-2020
DOI	10.1016/j.bbcan.2020.188362
Number of Authors	7
ISSN	0304-419X
EISSN	1879-2561
Journal	Biochim Biophys Acta Rev Cancer .
Listed In Thomson	True
Impact Factor	11.2
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	1873
Issue Number	2
Web Link	https://pubmed.ncbi.nlm.nih.gov/32298747/
Web Link Journal	https://www.sciencedirect.com/journal/biochimica-et-biophysica-acta-bba-reviews-on-cancer
Proof
Author Type	Co-Author
Author Serial	4
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

47.

Claudin-1, a double-edged sword in cancer

Acceptance Date	12-01-2020
Publication Date Online	15-01-2020
Publication Date	15-01-2020
DOI	10.3390/ijms21020569
Number of Authors	18
ISSN	1422-0067
EISSN	1422-0067
Journal	International Journal of Molecular Sciences
Listed In Thomson	True
Impact Factor	0
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	21
Issue Number	2
Web Link	https://www.mdpi.com/1422-0067/21/2/569
Web Link Journal	https://www.mdpi.com/journal/ijms
Proof
Author Type	Co-Author
Author Serial	6
Affiliating Institute	University of Nebraska Medical Center, Omaha, NE 68198, USA

48.

Bhat AA, Syed N, Therachiyil L, Nisar S, Hashem S, Krishnankuty R, Macha MA, Yadav SK, Bagga P, Reddy R, Shanmagaonkar M, Al-Naemi H, Dhawan P, Uddin S, El-Rifai W and Haris M (2020). Claudin-1, A Double-Edged Sword in Cancer. Int J Mol Sci. 21 (2):569 PM

Acceptance Date	13-01-2020
Publication Date Online	15-01-2020
Publication Date	15-01-2020
DOI	10.3390/ijms21020569
Number of Authors	1
ISSN	1422-0067
EISSN	1422-0067
Journal	Int J Mol Sci. 2020, 21 (2):569
Listed In Thomson	True
Impact Factor	6.2
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	2
Issue Number	14
Web Link	https://pubmed.ncbi.nlm.nih.gov/31952355/
Web Link Journal	https://www.mdpi.com/journal/ijms
Proof
Author Type	Co-Author
Author Serial	6
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

49.

Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells

Acceptance Date	18-06-2019
Publication Date Online	18-06-2019
Publication Date	03-06-2019
DOI	10.1186/s13046-019-1264-2
Number of Authors	11
ISSN	1756-9966
EISSN	1756-9966
Journal	JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Listed In Thomson	True
Impact Factor	11.5
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	38
Issue Number	1
Web Link	https://pubmed.ncbi.nlm.nih.gov/31215502/
Web Link Journal	https://jeccr.biomedcentral.com/
Proof
Author Type	Co-Author
Author Serial	2
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

50.

Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer.

Acceptance Date	05-03-2019
Publication Date Online	05-04-2019
Publication Date	05-04-2019
DOI	10.1016/j.ebiom.2019.03.056
Number of Authors	13
ISSN	2352-3964
EISSN	2352-3964
Journal	EBIOMEDICINE
Listed In Thomson	True
Impact Factor	11.1
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	42
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/30956167/
Web Link Journal	https://www.thelancet.com/journals/ebiom/home
Proof
Author Type	Co-Author
Author Serial	10
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

51.

Immunometabolic Alterations by HPV Infection: New Dimensions to Head and Neck Cancer Disparity.

Acceptance Date	05-02-2019
Publication Date Online	05-01-2019
Publication Date	05-01-2019
DOI	10.1093/jnci/djy207
Number of Authors	8
ISSN	1460-2105
EISSN	1460-2105
Journal	Journal of National Cancer Institute, 2019, 111(3):233-244
Listed In Thomson	True
Impact Factor	11.8
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	111
Issue Number	3
Web Link	https://pubmed.ncbi.nlm.nih.gov/30615137/
Web Link Journal	https://academic.oup.com/jnci
Proof
Author Type	Corresponding Author
Author Serial	8
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

52.

Novel Therapies Hijack the Blood Brain Barrier to Eradicate Glioblastoma Cancer Stem Cells

Acceptance Date	21-11-2018
Publication Date Online	24-11-2018
Publication Date	24-11-2018
DOI	10.1093/carcin/bgy171
Number of Authors	7
ISSN	0143-3334
EISSN	1460-2180
Journal	CARCINOGENESIS
Listed In Thomson	True
Impact Factor	4.8
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	40
Issue Number	1
Web Link	https://pubmed.ncbi.nlm.nih.gov/30475990/
Web Link Journal	https://academic.oup.com/carcin
Proof
Author Type	Corresponding Author
Author Serial	7
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

53.

Axed MUC4 (MUC4/X) aggravates pancreatic malignant phenotype by activating Integrin-β1FAK/ERK pathway

Acceptance Date	14-05-2018
Publication Date Online	16-05-2018
Publication Date	16-05-2018
DOI	10.1016/j.bbadis.2018.05.008
Number of Authors	7
ISSN	0925-4439
EISSN	1879-260X
Journal	Biochim Biophys Acta Mol Basis Dis .
Listed In Thomson	True
Impact Factor	6.2
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	1864
Issue Number	8
Web Link	https://pubmed.ncbi.nlm.nih.gov/29777904/
Web Link Journal	https://www.sciencedirect.com/journal/biochimica-et-biophysica-acta-bba-molecular-basis-of-disease
Proof
Author Type	Co-Author
Author Serial	2
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

54.

Emerging Therapeutic Potential of Graviola and its Constituents in Cancers

Acceptance Date	01-02-2018
Publication Date Online	15-02-2018
Publication Date	15-02-2018
DOI	10.1093/carcin/bgy024
Number of Authors	9
ISSN	0143-3334
EISSN	1460-2180
Journal	CARCINOGENESIS
Listed In Thomson	True
Impact Factor	4.8
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	39
Issue Number	4
Web Link	https://pubmed.ncbi.nlm.nih.gov/29462271/
Web Link Journal	https://academic.oup.com/carcin
Proof
Author Type	Corresponding Author
Author Serial	9
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

55.

Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells

Acceptance Date	06-02-2017
Publication Date Online	18-12-2017
Publication Date	18-12-2017
DOI	10.18632/oncotarget.15468
Number of Authors	21
ISSN	1949-2553
EISSN	1949-2553
Journal	Oncotarget
Listed In Thomson	True
Impact Factor	5.168
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	8
Issue Number	13
Web Link	https://pubmed.ncbi.nlm.nih.gov/28423495/
Web Link Journal	https://www.oncotarget.com/
Proof
Author Type	First Author
Author Serial	1
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

56.

MUC4 is negatively regulated through the Wnt/β-catenin pathway via the Notch effector Hath1 in colorectal cancer

Acceptance Date	16-06-2016
Publication Date Online	23-06-2016
Publication Date	23-06-2016
DOI	10.18632/genesandcancer.108
Number of Authors	11
ISSN	1947-6027
EISSN	1947-6027
Journal	Genes Cancer
Listed In Thomson	True
Impact Factor	1.95
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	7
Issue Number	5-6
Web Link	https://pubmed.ncbi.nlm.nih.gov/27551331/
Web Link Journal	https://www.genesandcancer.com/
Proof
Author Type	Co-Author
Author Serial	5
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

57.

The Canonical Wnt Pathway Regulates the Metastasis-Promoting Mucin MUC4 in Pancreatic Ductal Adenocarcinoma

Acceptance Date	09-10-2015
Publication Date Online	19-10-2015
Publication Date	19-10-2015
DOI	10.1016/j.molonc.2015.10.005
Number of Authors	8
ISSN	1878-0261
EISSN	1878-0261
Journal	Molecular Oncology
Listed In Thomson	True
Impact Factor	11.8
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	10
Issue Number	2
Web Link	https://pubmed.ncbi.nlm.nih.gov/26526617/
Web Link Journal	https://febs.onlinelibrary.wiley.com/journal/18780261
Proof
Author Type	Co-Author
Author Serial	4
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

58.

Micro RNA (miRNA) changes during the initiation and progression of pancreatic cancer in the genetically engineered mice

Acceptance Date	09-10-2015
Publication Date Online	19-10-2015
Publication Date	19-10-2015
DOI	10.18632/oncotarget.5641
Number of Authors	8
ISSN	1949-2553
EISSN	1949-2553
Journal	Oncotarget
Listed In Thomson	True
Impact Factor	5.168
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	6
Issue Number	37
Web Link	https://pubmed.ncbi.nlm.nih.gov/26516699/
Web Link Journal	https://www.oncotarget.com/
Proof
Author Type	Co-Author
Author Serial	2
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

59.

MUC4 Regulates Cellular Senescence in Head and Neck Squamous Cell Carcinoma (HNSCC) through p16/Rb Pathway.

Acceptance Date	21-05-2015
Publication Date Online	21-05-2015
Publication Date	21-05-2015
DOI	10.1038/onc.2014.102
Number of Authors	15
ISSN	0950-9232
EISSN	1476-5594
Journal	Oncogene
Listed In Thomson	True
Impact Factor	8.8
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	34
Issue Number	13
Web Link	https://pubmed.ncbi.nlm.nih.gov/24747969/
Web Link Journal	https://www.nature.com/onc/
Proof
Author Type	First Author
Author Serial	1
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

60.

Emerging Potential of Natural Products for Targeting Mucins for Therapy against Inflammation and Cancer.

Acceptance Date	01-01-2015
Publication Date Online	13-01-2015
Publication Date	13-01-2015
DOI	10.1016/j.ctrv.2015.01.001
Number of Authors	6
ISSN	0305-7372 \|
EISSN	0305-7372 \|
Journal	CANCER TREATMENT REVIEWS
Listed In Thomson	True
Impact Factor	11.8
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	41
Issue Number	3
Web Link	https://pubmed.ncbi.nlm.nih.gov/25624117/
Web Link Journal	https://www.cancertreatmentreviews.com/
Proof
Author Type	Corresponding Author
Author Serial	1
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

61.

Mucins in lung cancer: diagnostic, prognostic, and therapeutic implications.

Acceptance Date	01-12-2014
Publication Date Online	01-01-2015
Publication Date	01-01-2015
DOI	10.1097/JTO.0000000000000404
Number of Authors	9
ISSN	1556-0864
EISSN	1556-0864
Journal	J Thorac Oncol
Listed In Thomson	True
Impact Factor	20.4
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	10
Issue Number	1
Web Link	https://pubmed.ncbi.nlm.nih.gov/25319180/
Web Link Journal	https://www.jto.org/
Proof
Author Type	Co-Author
Author Serial	3
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

62.

Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer

Acceptance Date	24-10-2014
Publication Date Online	24-10-2014
Publication Date	24-10-2014
DOI	10.1016/j.addr.2014.10.020
Number of Authors	7
ISSN	0169-409X
EISSN	1872-8294
Journal	ADVANCED DRUG DELIVERY REVIEWS
Listed In Thomson	True
Impact Factor	16.1
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	81
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/25453266/
Web Link Journal	https://www.sciencedirect.com/journal/advanced-drug-delivery-reviews
Proof
Author Type	Co-Author
Author Serial	2
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

63.

Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma

Acceptance Date	12-05-2014
Publication Date Online	10-06-2014
Publication Date	10-06-2014
DOI	10.1007/s10147-014-0710-6
Number of Authors	9
ISSN	1341-9625
EISSN	Electronic ISSN 1437-7772
Journal	Int. J of Clinical Oncol
Listed In Thomson	True
Impact Factor	3.3
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	20
Issue Number	2
Web Link	https://pubmed.ncbi.nlm.nih.gov/24909613/
Web Link Journal	https://link.springer.com/journal/10147
Proof
Author Type	Co-Author
Author Serial	4
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

64.

MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers

Acceptance Date	01-01-2014
Publication Date Online	01-01-2014
Publication Date	01-01-2014
DOI	10.2174/1381612820666140128213117
Number of Authors	7
ISSN	1381-6128
EISSN	1873-4286
Journal	Curr Pharm Des
Listed In Thomson	True
Impact Factor	3.31
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	20
Issue Number	33
Web Link	https://pubmed.ncbi.nlm.nih.gov/24479799/
Web Link Journal	https://benthamscience.com/public/journals/current-pharmaceutical-design
Proof
Author Type	First Author
Author Serial	1
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

65.

Guggulsterone decreases proliferation and metastatic behavior of pancreatic cancer cells by modulating JAK/STAT and Src/FAK signaling

Acceptance Date	29-07-2013
Publication Date Online	03-08-2013
Publication Date	03-08-2013
DOI	10.1016/j.canlet.2013.07.037
Number of Authors	7
ISSN	0304-3835
EISSN	1872-7980
Journal	CANCER LETTERS
Listed In Thomson	True
Impact Factor	9.7
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	341
Issue Number	2
Web Link	https://pubmed.ncbi.nlm.nih.gov/23920124/
Web Link Journal	https://www.sciencedirect.com/journal/cancer-letters
Proof
Author Type	First Author
Author Serial	1
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

66.

Profile of Vismodegib and its potential in the treatment of advanced basal cell carcinoma.

Acceptance Date	19-04-2013
Publication Date Online	31-07-2013
Publication Date	31-07-2013
DOI	https://pubmed.ncbi.nlm.nih.gov/23940421/
Number of Authors	3
ISSN	1179-1322
EISSN	1179-1322
Journal	Cancer Manag. Res.
Listed In Thomson	True
Impact Factor	3.6
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	5
Issue Number	0
Web Link	https://pubmed.ncbi.nlm.nih.gov/23940421/
Web Link Journal	https://www.dovepress.com/cancer-management-and-research-journal
Proof
Author Type	First Author
Author Serial	1
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

67.

Expression of mucins in the progression of mouse pancreatic cancer in KrasG12D transgenic mouse model.

Acceptance Date	15-10-2012
Publication Date Online	26-10-2012
Publication Date	26-10-2012
DOI	10.1186/1756-8722-5-68
Number of Authors	14
ISSN	1756-8722
EISSN	1756-8722
Journal	JOURNAL OF HEMATOLOGY & ONCOLOGY
Listed In Thomson	True
Impact Factor	23.1
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	5
Issue Number	68
Web Link	https://pubmed.ncbi.nlm.nih.gov/23102107/
Web Link Journal	https://jhoonline.biomedcentral.com/
Proof
Author Type	Co-Author
Author Serial	6
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

68.

MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1

Acceptance Date	01-07-2012
Publication Date Online	12-07-2012
Publication Date	12-07-2012
DOI	10.1093/carcin/bgs225
Number of Authors	7
ISSN	0143-3334
EISSN	0143-3334
Journal	CARCINOGENESIS
Listed In Thomson	True
Impact Factor	4.8
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	33
Issue Number	10
Web Link	https://pubmed.ncbi.nlm.nih.gov/22791819/
Web Link Journal	https://academic.oup.com/carcin
Proof
Author Type	Co-Author
Author Serial	2
Affiliating Institute	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

69.

Prognostic significance of nuclear pSTAT3 in oral cancer

Acceptance Date	11-03-2011
Publication Date Online	11-04-2011
Publication Date	11-04-2011
DOI	10.1002/hed.21468
Number of Authors	8
ISSN	1043-3074
EISSN	1097-0347
Journal	Head and neck
Listed In Thomson	True
Impact Factor	7.8
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	33
Issue Number	4
Web Link	https://pubmed.ncbi.nlm.nih.gov/20652980/
Web Link Journal	https://onlinelibrary.wiley.com/journal/10970347
Proof
Author Type	First Author
Author Serial	1
Affiliating Institute	All India Institute of Medical Sciences

70.

Guggulsterone inhibits Smokeless Tobacco and Nicotine induced PI3K/Akt pathway in Head and Neck Cancer Cells.

Acceptance Date	24-01-2011
Publication Date Online	24-02-2011
Publication Date	24-02-2011
DOI	10.1371/journal.pone.0014728
Number of Authors	5
ISSN	1932-6203
EISSN	1932-6203
Journal	PLoS One
Listed In Thomson	True
Impact Factor	3.7
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	6
Issue Number	2
Web Link	https://pubmed.ncbi.nlm.nih.gov/21383988/
Web Link Journal	https://journals.plos.org/plosone/
Proof
Author Type	First Author
Author Serial	1
Affiliating Institute	All India Institute of Medical Sciences

71.

Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers

Acceptance Date	01-02-2011
Publication Date Online	06-02-2011
Publication Date	06-02-2011
DOI	10.1002/pmic.201000186
Number of Authors	6
ISSN	1615-9853
EISSN	1615-9861
Journal	PROTEOMICS
Listed In Thomson	True
Impact Factor	3.4
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	11
Issue Number	12
Web Link	https://pubmed.ncbi.nlm.nih.gov/21598386/
Web Link Journal	https://analyticalsciencejournals.onlinelibrary.wiley.com/journal/16159861/journal-metrics
Proof
Author Type	Co-Author
Author Serial	5
Affiliating Institute	All India Institute of Medical Sciences

72.

Guggulsterone (GS) Inhibits Smokeless Tobacco and Nicotine Induced NF-kB and STAT3 pathways in Head and Neck Cancer cells.

Acceptance Date	08-12-2010
Publication Date Online	22-12-2010
Publication Date	22-12-2010
DOI	10.1093/carcin/bgq278
Number of Authors	1
ISSN	0143-3334
EISSN	1460-2180
Journal	CARCINOGENESIS
Listed In Thomson	True
Impact Factor	4.8
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	32
Issue Number	3
Web Link	https://pubmed.ncbi.nlm.nih.gov/21177768/
Web Link Journal	https://academic.oup.com/carcin
Proof
Author Type	First Author
Author Serial	1
Affiliating Institute	All India Institute of Medical Scieneces

73.

14-3-3 zeta is a Molecular Target in Guggulsterone Induced Apoptosis in Head and Neck Cancer Cells.

Acceptance Date	30-11-2010
Publication Date Online	30-11-2010
Publication Date	30-11-2010
DOI	10.1186/1471-2407-10-655
Number of Authors	5
ISSN	1471-2407
EISSN	1471-2407
Journal	BMC Cancer
Listed In Thomson	True
Impact Factor	4.3
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	10
Issue Number	0
Web Link	https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-10-655
Web Link Journal	https://bmccancer.biomedcentral.com/
Proof
Author Type	First Author
Author Serial	1
Affiliating Institute	All India Institute of Medical Sciences

74.

Clinical significance of TC21/R-Ras2 over expression in Oral Cancer.

Acceptance Date	01-07-2010
Publication Date Online	10-07-2010
Publication Date	10-07-2010
DOI	10.1111/j.1600-0714.2009.00854.x
Number of Authors	6
ISSN	0904-2512
EISSN	1600-0714
Journal	Journal of Oral Pathol and Med.
Listed In Thomson	True
Impact Factor	4.1
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	39
Issue Number	6
Web Link	https://pubmed.ncbi.nlm.nih.gov/20040018/
Web Link Journal	https://onlinelibrary.wiley.com/journal/16000714
Proof
Author Type	First Author
Author Serial	1
Affiliating Institute	All India Institute of Medical Sciences

75.

Promoter hypermethylation in Indian primary oral squamous cell carcinoma

Acceptance Date	05-03-2010
Publication Date Online	05-04-2010
Publication Date	05-04-2010
DOI	10.1002/ijc.25377
Number of Authors	7
ISSN	0020-7136
EISSN	1097-0215
Journal	Int. J Cancer.
Listed In Thomson	True
Impact Factor	7.396
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	127
Issue Number	10
Web Link	https://pubmed.ncbi.nlm.nih.gov/20473870/
Web Link Journal	https://onlinelibrary.wiley.com/journal/10970215
Proof
Author Type	Co-Author
Author Serial	4
Affiliating Institute	All India Institute of Medical Sciences

76.

Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue

Acceptance Date	01-05-2009
Publication Date Online	08-05-2009
Publication Date	08-05-2009
DOI	10.1002/hed.21122
Number of Authors	6
ISSN	1043-3074
EISSN	1097-0347
Journal	Head and Neck
Listed In Thomson	True
Impact Factor	2.9
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	31
Issue Number	11
Web Link	https://pubmed.ncbi.nlm.nih.gov/19431196/
Web Link Journal	https://onlinelibrary.wiley.com/journal/10970347
Proof
Author Type	Co-Author
Author Serial	4
Affiliating Institute	All India Institute of Medical Sciences

77.

Cytoplasmic accumulation of Activated Leukocyte Cell Adhesion is a predictor of disease Progression and reduced survival in oral cancer patients

Acceptance Date	09-02-2009
Publication Date Online	24-02-2009
Publication Date	24-02-2009
DOI	10.1002/ijc.24192
Number of Authors	7
ISSN	0020-7136
EISSN	1097-0215
Journal	Int. J Cancer
Listed In Thomson	True
Impact Factor	6.4
Source of Impact Factor	Thomson Reuters
UGC Care List	UGC-CARE List Group II (Both Scopus and Web of Science)
Volume Number	124
Issue Number	9
Web Link	Cytoplasmic accumulation of Activated Leukocyte Cell Adhesion is a predictor of disease Progression and reduced survival in oral cancer patients
Web Link Journal	https://onlinelibrary.wiley.com/journal/10970215/journal-metrics
Proof
Author Type	Co-Author
Author Serial	3
Affiliating Institute	All India Institute of Medical Sciences

Overview

31

Total

Level	Total
International (Abroad)	27
International (Within Country)	2
National	1
University	1

Conference / Seminar Details

Participation	Paper Title	Title of Conference/Seminar	ISBN	From	To
Paper Presented / Published	Nuclear receptor subfamily 4A2: Novel Role and a potential therapeutic lead in cancers	American Society for Clinical Oncology, Chicago, USA	00000000	24-05-2024	24-05-2024
Paper Presented / Published	Development of liquid biopsy HPV (Human Papilloma Virus) cell free DNA (cfDNA) based approach for prognosis of cervical cancer	American Association for Cancer Research Annual Meeting Apr 5-10; 2024. San Diego, CA. Philadelphia (PA): AACR	00000000	05-04-2024	10-04-2024
Paper Presented / Published	Bergenin inhibits growth of human cervical cancer cells by decreasing galectin-3 and MMP-9 expression	American Association for Cancer Research Annual Meeting Apr 5-10; 2024. San Diego, CA. Philadelphia (PA):	00000000	05-04-2024	10-04-2024
Keynote Speaker / Invited Talk	GI Cancer on the Rise: Novel Treatment Modalities	Seminar Series, King Fahad Medical Research Centre, KAU Saudi Arabia		27-07-2023	27-07-2023
Keynote Speaker / Invited Talk	Role of NR4A2 in Cancers and Beyond	Departmental Seminar Series at Sidra Medicine, Doha, Qatar		21-04-2023	21-04-2023
Paper Presented / Published	Ubiquitin Specific Peptidase 37 promotes Osteosarcoma oncogenesis by interacting with PCNA and impacting constitutive replication	American Association for Cancer Research. Annual Meeting 2023; Apr 14-19; Orlando, FL. Philadelphia (PA)	00000000	14-04-2023	19-04-2023
Paper Presented / Published	Ubiquitin Specific Peptidase 37 promotes Osteosarcoma oncogenesis by interacting with PCNA and impacting constitutive replication	American Association for Cancer Research Annual Meeting, Orlando, FL. Philadelphia, USA. Apr 14-19, 2023	1538-7445	14-04-2023	19-04-2023
Participiant		Innovations and Entrepreneurship for Sustainable Development (IESD-2022).		20-12-2022	21-12-2022
Paper Presented / Published	Bioinformatics Analysis of lncRNA-miRNA-mRNA Identifies Key Prognostic Biomarkers in Gastric Adenocarcinoma	The 1st Advances in Precision Medicine (APM2021), Hamad Bin Khalifa University (HBKU), Education City, Qatar, Nov. 29th - 1st December, 2022). Doha Qatar.		29-11-2022	01-12-2022
Participiant		Role of Artificial Intelligence & Information Technology in Surgery & Medical Research		28-09-2022	29-09-2022
Paper Presented / Published	CLOCK-LIKE SBS5 MUTATATIONAL SIGNATURE IS AN INDEPENDENT PREDICTOR OF METASTASIS AND OVERALL SURVIVAL IN COLORECTAL CANCER	Digestive Disease Week® (DDW) 2022. May 21-24, 2022). San Diego Convention Center in San Diego, CA	111111	21-05-2022	25-05-2022
Paper Presented / Published	Tandem use of Multi-omics and Artificial Intelligence Identified Novel Prognostic and Therapeutic Biomarkers for Head and Neck Squamous Cell Carcinoma	Annual American association of cancer research, Apr 8-13, 2022. Philadelphia (PA), USA	1538-7445	08-04-2022	13-04-2022
Keynote Speaker / Invited Talk	Novel Therapeutics for Head and Neck Cancer	Emerging Trends in Translational Oncology.		18-02-2022	19-02-2022
Paper Presented / Published	Deregulation of NOTCH 1/NR4A2 Signaling Axis in Head and Neck Cancer Pathogenesis	Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research, Austin, Texas, USA 2019	1557-3265	29-04-2019	30-04-2019
Paper Presented / Published	Afatinib targets Glioblastoma stem cells by inhibiting EGFRVIII-cMet co-activation	Annual American association of cancer research, Atlanta, USA-2019.	1538-7445	29-03-2019	03-04-2019
Paper Presented / Published	Mechanistic Implications of Trefoil Factor 1 (TFF1) in Pancreatic Cancer Chemoresistance	49th Annual Meeting of the American Pancreatic Association, October 31 – November 3, 2018, Miami Beach, Florida, USA	1590-8577	31-10-2018	03-11-2018
Paper Presented / Published	NR4A2 role in head and neck cancer: mechanistic and functional analysis	Annual American association of cancer research, Chicago, USA-2018	1538-7445	14-04-2018	18-04-2018
Paper Presented / Published	Pathobiological implications of Trefoil Factors in the progression and metastasis of pancreatic cancer	American association of cancer research, Washington DC, USA- April 1 - 5, 2017	1538-7445	01-04-2017	05-04-2017
Paper Presented / Published	Pathobiological implications of Trefoil Factors in the progression and metastasis of pancreatic cancer	American association of cancer research, Washington DC, USA- April 1 - 5, 2017	1538-7445	01-04-2017	05-04-2017
Paper Presented / Published	Targeting Pancreatic Cancer Stem Cells by Afatanib in Organoid Culture	107th American association of cancer research, New Orleans, Louisiana, USA- April 16-20, 2016	1538-7445	01-04-2017	05-04-2017
Paper Presented / Published	Targeting Endothelin Axis in Pancreatic Tumor Microenvironment	Pancreatic Association and Japan Pancreas Society, November 5-8, 2014, Kohala Coast, Hawaii, USA	1590-8577	05-11-2014	08-11-2014
Paper Presented / Published	β-catenin and MUC4 in the Pathogenies of Pancreatic Cancer	American Pancreatic Association and Japan Pancreas Society, November 5-8, 2014, Kohala Coast, Hawaii, USA	1590-8577	05-11-2014	08-11-2014
Paper Presented / Published	SORBS1 Expression as a Biomarker for Obesity and Breast Cancer Prognosis: Insights from Genomic Analysis and Survival Outcomes	American Society for Clinical Oncology, Chicago, USA.	00000000	24-05-2014	24-05-2014
Paper Presented / Published	Unraveling the oncogenic network of USP37 and USP14 in gynecological cancers: Decrypting the molecular landscape of chemoresistance	. American Association for Cancer Research Annual Meeting Apr 5-10; 2024. San Diego, CA. Philadelphia (PA): AACR	00000000	05-04-2014	10-04-2014
Paper Presented / Published	Prognostic significance and immune infiltration patterns related to Claudin heterogeneity in pancreatic ductal adenocarcinoma patients	American Association for Cancer Research Annual Meeting Apr 5-10; 2024. San Diego, CA. Philadelphia (PA): AACR	00000000	05-04-2014	10-04-2014
Paper Presented / Published	Pathbiological Implications of Endothelin axis in pancreatic cancer	44th Meeting of the American Pancreatic Association, October 30-November 2, 2013, Miami, Florida, USA	1590-8577	30-10-2013	02-11-2013
Paper Presented / Published	MUC4 knockdown induces Senescence in Head and Neck Cancer Cells: A novel mechanism	104th Annual American association of cancer research, Washington DC, USA- April 6-10, 2013	1538-7445	06-04-2013	10-04-2013
Paper Presented / Published	The Novel Sterol Guggulsterone Modulates Novel microRNAs Targeting MUC4 Expression in Pancreatic Cancer Cells	42nd Annual Meeting, American Pancreatic Association, Chicago, USA, November 2-5, 2011	1590-8577	02-11-2011	05-11-2011
Paper Presented / Published	Downregulation of MUC4 by the Extract and Essential Oil of Holy Basil Leaves Suggests a Potential for Basil as a Novel Therapeutic Adjuvant in Pancreatic Cancer.	42nd Annual Meeting, American Pancreatic Association, Chicago, USA, November 2-5- 2011	1590-8577	02-11-2011	05-11-2011
Paper Presented / Published	MUC4 induces Epithelial to Mesenchymal Transition through N-Cadherin up regulation in pancreatic cancer	42nd Annual Meeting, American Pancreatic Association, Chicago, USA	1590-8577	02-11-2011	05-11-2011
Paper Presented / Published	Molecular targets of compound X in head and neck cancer	American Association of Cancer Research, Molecular Diagnostics in Cancer Therapeutic Development, Sep 22-25, 2008; Philadelphia, PA	1557-3265	22-09-2008	25-09-2008

Overview

6

Total Books

8

Book Chapters

PublicationType	Participation	Total
Chapter	Authored	5
Book	Edited	6
Chapter	Edited	3

Books / Chapters Details

Title of Book :

Multi-omics in Health and Diseases

Book ( Edited ) | Publisher : Elsevier |

Title of Chapter :

Participation	Affiliating Institute
Editor	Islamic University of Science and Technology

Title of Book :

Neglected and Underutilized Crops for Cancer Prevention and Therapy

Book ( Edited ) | Publisher : CRC Taylor Francis press |

Title of Chapter :

Participation	Affiliating Institute
Editor	Islamic University of Science and Technology

Title of Book :

Alternative Splicing and Cancer

Book ( Edited ) | Publisher : CRC Taylor Francis |

Title of Chapter :

Participation	Affiliating Institute
Editor	Islamic University of sciences and technology

Title of Book :

Management of Oral Cancers

Chapter ( Authored ) | Publisher : Springer Nature |

Title of Chapter : Recent Advances in Oral Cancer Research

Participation	Affiliating Institute
Co-Author	Central University of Kashmir

Title of Book :

Tight Junctions In Inflammation And Cancer

Book ( Edited ) | Publisher : Springer Nature |

Title of Chapter :

Participation	Affiliating Institute
Editor	Islamic University of sciences and technology

Title of Book :

Tight Junctions in Inflammation and Cancer

Chapter ( Edited ) | Publisher : Springer Nature |

Title of Chapter : Tight Junctions, Epithelial-Mesenchymal Transition, and Cancer Metastasis

Participation	Affiliating Institute
Main Author	Islamic University of sciences and technology

Title of Book :

Encyclopedia of Signaling Molecules

Chapter ( Authored ) | Publisher : Springer New York |

Title of Chapter : MUCINS

Participation	Affiliating Institute
Co-Author	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

Title of Book :

Inflammation And Cancer: Role Of Tight Junctions

Chapter ( Edited ) | Publisher : Springer Nature |

Title of Chapter : Tight Junctions and Signaling Pathways in Cancer

Participation	Affiliating Institute
Main Author	Islamic University of sciences and technology

Title of Book :

Gene Regulation & Therapeutics. Science

Chapter ( Authored ) | Publisher : CRC Press |

Title of Chapter : Receptor Tyrosine Kinase Signaling Pathways as a Goldmine for Targeted Therapy in Head and Neck Cancers

Participation	Affiliating Institute
Main Author	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

Title of Book :

Adv Exp Med Biol

Chapter ( Authored ) | Publisher : Springer publications |

Title of Chapter : Recent Advances in Head and Neck TumorMicroenvironment-Based Therapy

Participation	Affiliating Institute
Main Author	Central University of Kashmir

Title of Book :

Inflammation and Cancer: Role of Tight Junctions

Chapter ( Edited ) | Publisher : Springer Nature |

Title of Chapter : Molecular Architecture and Function of Tight Junctions

Participation	Affiliating Institute
Main Author	Islamic University of sciences and technology

Title of Book :

Immuno-Oncology Crosstalk and Metabolism

Book ( Edited ) | Publisher : Springer Nature |

Title of Chapter :

Participation	Affiliating Institute
Editor	Islamic University of sciences and technology

Title of Book :

Microbes and Oral Squamous Cell Carcinoma

Chapter ( Authored ) | Publisher : Springer Nature |

Title of Chapter : Viral-Induced Carcinopathogenesis in Oral Squamous Cell Carcinoma

Participation	Affiliating Institute
Co-Author	Islamic University of sciences and technology

Title of Book :

Modern technology: Present and Future of Cancer

Book ( Edited ) | Publisher : OMICS Group International |

Title of Chapter :

Participation	Affiliating Institute
Editor	University of Nebraska Medical Centre, Omaha,, Nebraska, USA

Overview

8

Total

Project Status	Total Projects	Grant In Aid
Ongoing	8	₹12,61,20,419.00

Projects Details

Investigate the Therapeutic and Chemo-Sensitizing Efficacy of Unani Pharmacopoeial formulation Dawa-Ul-kurkum on Head and Neck Squamous Cell Carcinoma

(CCRUM) Ministry of AYUSH, GoI ( PI ) |

Grant In Aid	Tenure In Months	Year	Status
₹39,28,760.00	36	30-12-2024	Ongoing

Artificial intelligence based deep learning model to predict human papilloma virus infection in Head and Neck squamous cell carcinoma patients using Histopathology images

JKST&IC ( Co-PI ) |

Grant In Aid	Tenure In Months	Year	Status
₹3,70,000.00	24	27-12-2023	Ongoing

Development and Characterization of Novel in vitro models for Gastric Cancers from Kashmiri Patients

JKST&IC ( PI ) |

Grant In Aid	Tenure In Months	Year	Status
₹3,50,000.00	24	27-12-2023	Ongoing

Artificial intelligence Based Deep Learning Model to Predict Gastric Cancer Tumor Heterogeneity and Therapeutic Response Using Histopathology Images

ICMR ( PI ) |

Grant In Aid	Tenure In Months	Year	Status
₹20,79,557.00	24	01-11-2023	Ongoing

Establishment of an interdisciplinary Science and Technology Research Program for Chronic Diseases,

DST PURSE ( Co-PI ) |

Grant In Aid	Tenure In Months	Year	Status
₹9,76,13,800.00	48	23-06-2023	Ongoing

Systems biology-based identification and validation of potential novel therapeutic agents for Head and Neck Squamous Cell Carcinoma

SERB-DST ( PI ) |

Grant In Aid	Tenure In Months	Year	Status
₹51,10,120.00	36	12-01-2022	Ongoing

To Study the Novel Role of Cullin- 3 SPOP E3 Ligase mediated immune surveillance in Prostate Cancer by promoting the degradation of Next generation immune checkpoint inhibitor CD73

SERB-DST ( Co-PI ) |

Grant In Aid	Tenure In Months	Year	Status
₹50,34,832.00	36	12-01-2022	Ongoing

Development and characterization of in vitro models to identify novel therapeutic targets for Indian Esophageal Cancer patients.

DBT ( PI ) |

Grant In Aid	Tenure In Months	Year	Status
₹1,16,33,350.00	60	21-12-2020	Ongoing

Overview

Total

5

Participation

Name	Participation	Total
Oreintation Course	Participant	1
Program	Organizer	1
Program	Participant	1
Workshop	Participant	2

Duration

Duration	Total
Less Than One Week	3
More Than Four Week	1
Three Week	1

Year Wise

Year Wise	Total
2020	1
2021	2
2022	1
2023	1

FDP / Workshop Details

Name	Title	Agency	Funding Agency	Duration	Mode	From	To
Program	Innovation Ambassador Training	MoE's Innovation Cell & AICTE	NA	Three Week	Online	26-07-2023	25-08-2023
Program	NATIONAL INTELLECTUAL PROPERTY AWARENESS MISSION	IUST	IUST	Less Than One Week	Offline	28-04-2022	28-04-2022
Oreintation Course	INDUCTION TRAINING/ ORIENTATION PROGRAMME FOR FACULTY	Ramanujan College, University of Delhi	SELF	More Than Four Week	Online	19-11-2021	20-12-2021
Workshop	INTERNATIONAL WEBINAR On “Synthetic Biology: Concepts to Applications	DEPARTMENT OF BIOTECHNOLOGY Central University of Kashmir	SELF	Less Than One Week	Online	17-06-2021	17-06-2021
Workshop	Plagiarism - An Opportunity to Learn, Teach & Excel	Department of Bioresources University of Kashmir	SELF	Less Than One Week	Online	24-06-2020	24-06-2020

Overview

6

Total

Supervision	PrgCode	Status	Total
Supervisor	Ph.D. (CS)	Under Superviosn	1
Supervisor	Ph.D. (CS)	Awarded	1
Supervisor	Ph.D. (MM)	Under Superviosn	4

Research Guidance Details

RegistrationNo	PrgCode	Batch	ResearchTopic	FellowshipName
IUST0123017729	Ph.D. (MM)	2023	Development and Characterization of Novel in Vitro Models for Gastrointestinal Tract Cancers from Kashmiri Patients	PROJECT FELLOW
IUST0123017772	Ph.D. (MM)	2023	Not Assigned Yet	NILL
IUST0121015678	Ph.D. (MM)	2021	not assigned yet	PROJECT FELLOW
IUST0120014326	Ph.D. (MM)	2020	Not Assigned Yet	IUST-Fellowship
IUST0119013139	Ph.D. (CS)	2019	Leveraging Artificial Intelligence to Identify Deregulated Oncogenic Signalling Pathways in Brain Tumors from Magnetic Resonance Imaging (MRI)
IUST0119013137	Ph.D. (CS)	2019	Identification of Deregulated Oncogenic Signalling Pathways and Risk of Metastasis in Esophageal Cancer based on H&E Stained Digiral Histopathological Data using Artificial Intelligence

Overview

Awards

Level Total
International 5
National 7

Patents

PatentType PatentStatus Total
Design Granted 1
Patent Published 3

Award Details

Level Type AwardName AwardingAgency Year
International Award Best performance stipend Dept. of Biochemistry and Molecular Biology, UNMC, USA. 2013
International Award Best performance stipend Dept. of Biochemistry and Molecular Biology, UNMC, USA 2012
National Award Gita Mittal Award/Gold Medal All India Institute of Medical Sciences (AIIMS), New Delhi, India for Ph.D. 2011
International Award Young Investigator Award Human Proteome Organization (HUPO), Toronto, Canada. 2009
National Fellowship Ramalingaswami Re-entry Fellowship Dept. of Biotechnology, Govt. of India 2020
International Award Scholar-In-Training award AACR to attend Advances in Cancer Research: From the Laboratory to the Clinic, Jordan. 2010
National Fellowship National Eligibility Test (Dec.) CSIR - UGC, India. 2005
National Fellowship National Eligibility Test (June) (NET) CSIR - UGC, India. 2004
International Award Educational Scholarship award National Drug Development Office (NDDO) to attend the 8th international symposium on Targeted Antica 2010
National Fellowship Junior Research Fellowship/Senior Research Fellowship Council of Scientific and Industrial Research (CSIR), New Delhi, India. 2005
National Fellowship Ramanujan Fellowship Science and Engineering Research Board (SERB), Dept. of Science and Technology, Govt. of India 2019
National Award University Gold Medal Jamia Hamdard, New Delhi, India 2008

Patent Details

ApplicationNo PatentTitle FilingDate PublishingDate PatentType PatentStatus
6945/2022-CO/SW ARTIFICIAL INTELLIGENCE BASED SYSTEM FOR PASHMINA ARTWORK IDENTIFICATION AND CLASSIFICATION 20-05-2019 14-01-2022 Design Granted
202211018901 SYSTEM AND METHOD FOR DETECTING AND CLASSIFYING PASHMINA SHAWL 30-03-2022 08-04-2022 Patent Published
202311027701 AN ARTIFICIAL-INTELLIGENCE/MACHINE LEARNING-BASED SYSTEM FOR PREDICTING CERVICAL CANCER SUBTYPES USING HAEMATOXYLIN AND EOSIN WHOLE-SLIDE IMAGES 14-04-2023 19-05-2023 Patent Published
202311050226 A SYSTEM AND METHOD FOR EARLY PREDICTION OF ESOPHAGEAL CANCER SUBTYPES FROM HISTOPATHOLOGY IMAGES 25-07-2023 25-08-2023 Patent Published

Level	Type	AwardName	AwardingAgency	Year
International	Award	Best performance stipend	Dept. of Biochemistry and Molecular Biology, UNMC, USA.	2013
International	Award	Best performance stipend	Dept. of Biochemistry and Molecular Biology, UNMC, USA	2012
National	Award	Gita Mittal Award/Gold Medal	All India Institute of Medical Sciences (AIIMS), New Delhi, India for Ph.D.	2011
International	Award	Young Investigator Award	Human Proteome Organization (HUPO), Toronto, Canada.	2009
National	Fellowship	Ramalingaswami Re-entry Fellowship	Dept. of Biotechnology, Govt. of India	2020
International	Award	Scholar-In-Training award	AACR to attend Advances in Cancer Research: From the Laboratory to the Clinic, Jordan.	2010
National	Fellowship	National Eligibility Test (Dec.)	CSIR - UGC, India.	2005
National	Fellowship	National Eligibility Test (June) (NET)	CSIR - UGC, India.	2004
International	Award	Educational Scholarship award	National Drug Development Office (NDDO) to attend the 8th international symposium on Targeted Antica	2010
National	Fellowship	Junior Research Fellowship/Senior Research Fellowship	Council of Scientific and Industrial Research (CSIR), New Delhi, India.	2005
National	Fellowship	Ramanujan Fellowship	Science and Engineering Research Board (SERB), Dept. of Science and Technology, Govt. of India	2019
National	Award	University Gold Medal	Jamia Hamdard, New Delhi, India	2008

ApplicationNo	PatentTitle	FilingDate	PublishingDate	PatentType	PatentStatus
6945/2022-CO/SW	ARTIFICIAL INTELLIGENCE BASED SYSTEM FOR PASHMINA ARTWORK IDENTIFICATION AND CLASSIFICATION	20-05-2019	14-01-2022	Design	Granted
202211018901	SYSTEM AND METHOD FOR DETECTING AND CLASSIFYING PASHMINA SHAWL	30-03-2022	08-04-2022	Patent	Published
202311027701	AN ARTIFICIAL-INTELLIGENCE/MACHINE LEARNING-BASED SYSTEM FOR PREDICTING CERVICAL CANCER SUBTYPES USING HAEMATOXYLIN AND EOSIN WHOLE-SLIDE IMAGES	14-04-2023	19-05-2023	Patent	Published
202311050226	A SYSTEM AND METHOD FOR EARLY PREDICTION OF ESOPHAGEAL CANCER SUBTYPES FROM HISTOPATHOLOGY IMAGES	25-07-2023	25-08-2023	Patent	Published

Dr. Muzafar Ahmad Macha

Curriculum Vitae

Contact Info

Research Links

Overview

77

31

6

8

8

5

5

4

Overview

77

Publication Details

Overview

31

Conference / Seminar Details

Overview

6

8

Books / Chapters Details

Overview

8

Projects Details

Overview

5

FDP / Workshop Details

Overview

6

Research Guidance Details

Overview

LevelTotal International5 National7

PatentTypePatentStatusTotal DesignGranted1 PatentPublished3

Level Total
International 5
National 7

PatentType PatentStatus Total
Design Granted 1
Patent Published 3